Vista Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Vista Pharmaceuticals has a total shareholder equity of ₹404.6M and total debt of ₹79.6M, which brings its debt-to-equity ratio to 19.7%. Its total assets and total liabilities are ₹579.8M and ₹175.2M respectively.
Key information
19.7%
Debt to equity ratio
₹79.65m
Debt
| Interest coverage ratio | n/a |
| Cash | ₹944.00k |
| Equity | ₹404.62m |
| Total liabilities | ₹175.17m |
| Total assets | ₹579.79m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524711's short term assets (₹234.0M) exceed its short term liabilities (₹144.9M).
Long Term Liabilities: 524711's short term assets (₹234.0M) exceed its long term liabilities (₹30.2M).
Debt to Equity History and Analysis
Debt Level: 524711's net debt to equity ratio (19.5%) is considered satisfactory.
Reducing Debt: 524711's debt to equity ratio has reduced from 31.2% to 19.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 524711 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 524711 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15.6% each year